Markedly increased plasma IL-18 levels are also present in patients with systemic juvenile idiopathic arthritis (sJIA) or systemic inflammatory adult-onset Still’s disease (AOSD), which are at high risk of developing life-threatening MAS (43, 48, 50–52). This evidence concerns the gene IL18 and macrophage activation syndrome.